PMID- 28077133 OWN - NLM STAT- MEDLINE DCOM- 20171212 LR - 20240117 IS - 1532-429X (Electronic) IS - 1097-6647 (Print) IS - 1097-6647 (Linking) VI - 19 IP - 1 DP - 2017 Jan 6 TI - T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides. PG - 6 LID - 10.1186/s12968-016-0315-5 [doi] LID - 6 AB - BACKGROUND: Myocardial involvement in AAV patients might be silent, presenting with no or nonspecific symptoms, normal ECG, and preserved left-ventricular ejection fraction (LV-EF). Since up to 50% of deaths in these patients may be due to myocardial involvement, a reliable diagnostic tool is warranted. In contrast to LGE-CMR, which has its strengths in detecting focal inflammatory or fibrotic processes, recent mapping techniques are able to detect even subtle, diffuse inflammatory or fibrotic processes. Our study sought to investigate ANCA (antineutrophil cytoplasmic antibody) associated vasculitides (AAV) patients for myocardial involvement by a cardiovascular magnetic resonance (CMR) protocol, including late gadolinium enhancement (LGE) and mapping sequences. METHODS: Thirty seven AAV patients were prospectively enrolled and underwent CMR imaging. Twenty healthy volunteers served as controls. RESULTS: Mean LV-EF was 64%; LGE prevalence of the AAV patients was 43%. AAV patients had higher median native T1 (988 vs. 952 ms, p < 0.001), lower post-contrast T1 (488 vs. 524 ms, p = 0.03), expanded extracellular volume (ECV) (27.5 vs. 24.5%, p < 0.001), and higher T2 (53 vs. 49 ms, p < 0.001) compared to controls, with most parameters independent of the LGE status. Native T1 and T2 in AAV patients showed the highest prevalence of abnormally increased values beyond the 95% percentile of controls. CONCLUSION: AAV patients demonstrated increased T1, ECV, and T2 values, with native T1 and T2 showing the highest prevalence of values beyond the 95% percentile of normal. Since these findings seem to be independent of LGE, mapping techniques may provide complementary information to LGE-CMR in the assessment of myocardial involvement in patients with AAV. FAU - Greulich, Simon AU - Greulich S AD - Division of Cardiology, Robert-Bosch-Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany. simon.greulich@rbk.de. FAU - Mayr, Agnes AU - Mayr A AD - Division of Radiology, University Hospital Innsbruck, Innsbruck, Austria. FAU - Kitterer, Daniel AU - Kitterer D AD - Division of Nephrology, Department of Internal Medicine, Robert-Bosch-Medical Center, Stuttgart, Germany. FAU - Latus, Joerg AU - Latus J AD - Division of Nephrology, Department of Internal Medicine, Robert-Bosch-Medical Center, Stuttgart, Germany. FAU - Henes, Joerg AU - Henes J AD - Center for Interdisciplinary Clinical Immunology, Rheumatology and Auto-inflammatory Diseases, University Hospital Tuebingen, Tuebingen, Germany. FAU - Steubing, Hannah AU - Steubing H AD - Division of Cardiology, Robert-Bosch-Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany. FAU - Kaesemann, Philipp AU - Kaesemann P AD - Division of Cardiology, Robert-Bosch-Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany. FAU - Patrascu, Alexandru AU - Patrascu A AD - Division of Cardiology, Robert-Bosch-Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany. FAU - Greiser, Andreas AU - Greiser A AD - Siemens Healthcare GmbH, Erlangen, Germany. FAU - Groeninger, Stefan AU - Groeninger S AD - Siemens Healthcare GmbH, Erlangen, Germany. FAU - Braun, Niko AU - Braun N AD - Division of Nephrology, Department of Internal Medicine, Robert-Bosch-Medical Center, Stuttgart, Germany. FAU - Alscher, M Dominik AU - Alscher MD AD - Division of Nephrology, Department of Internal Medicine, Robert-Bosch-Medical Center, Stuttgart, Germany. FAU - Sechtem, Udo AU - Sechtem U AD - Division of Cardiology, Robert-Bosch-Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany. FAU - Mahrholdt, Heiko AU - Mahrholdt H AD - Division of Cardiology, Robert-Bosch-Medical Center, Auerbachstrasse 110, 70376, Stuttgart, Germany. LA - eng PT - Journal Article DEP - 20170106 PL - England TA - J Cardiovasc Magn Reson JT - Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance JID - 9815616 RN - 0 (Contrast Media) RN - K2I13DR72L (Gadolinium DTPA) SB - IM MH - Adult MH - Aged MH - Cardiomyopathies/*diagnostic imaging/etiology/pathology/physiopathology MH - Case-Control Studies MH - Churg-Strauss Syndrome/*complications/diagnosis MH - Contrast Media/administration & dosage MH - Female MH - Fibrosis MH - Gadolinium DTPA/administration & dosage MH - Granulomatosis with Polyangiitis/*complications/diagnosis MH - Humans MH - Image Interpretation, Computer-Assisted MH - *Magnetic Resonance Imaging, Cine MH - Male MH - Middle Aged MH - Myocarditis/*diagnostic imaging/etiology/pathology/physiopathology MH - Myocardium/*pathology MH - Predictive Value of Tests MH - Prospective Studies MH - Stroke Volume MH - Ventricular Function, Left PMC - PMC5225624 OTO - NOTNLM OT - ANCA-associated vasculitides OT - CMR OT - Cardiac involvement OT - LGE OT - T1 mapping OT - T2 mapping EDAT- 2017/01/13 06:00 MHDA- 2017/12/13 06:00 PMCR- 2017/01/06 CRDT- 2017/01/13 06:00 PHST- 2016/10/16 00:00 [received] PHST- 2016/12/09 00:00 [accepted] PHST- 2017/01/13 06:00 [entrez] PHST- 2017/01/13 06:00 [pubmed] PHST- 2017/12/13 06:00 [medline] PHST- 2017/01/06 00:00 [pmc-release] AID - S1097-6647(23)01040-2 [pii] AID - 315 [pii] AID - 10.1186/s12968-016-0315-5 [doi] PST - epublish SO - J Cardiovasc Magn Reson. 2017 Jan 6;19(1):6. doi: 10.1186/s12968-016-0315-5.